Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion

Home
/
Publication
/
Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion

Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion

Réference
Leukemia Research 35 (2011) e175-e176

Auteurs
Sondes Hadiji Mseddi ,Faten Kallel Olfa Kassar Moez Elloumi Department of Hematology, University of Sfax, HediChaker Hospital, Sfax, Tunisia Ines Jedidi Hematology Laboratory, Habib Bourguiba Hospital, Sfax, Tunisia

Date de publication
11/06/2011